NO140594C - Analogifremgangsmaate for fremstilling av farmakologisk aktive n-(1-(omega-fenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-karboksylsyreamider - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive n-(1-(omega-fenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-karboksylsyreamider

Info

Publication number
NO140594C
NO140594C NO742970A NO742970A NO140594C NO 140594 C NO140594 C NO 140594C NO 742970 A NO742970 A NO 742970A NO 742970 A NO742970 A NO 742970A NO 140594 C NO140594 C NO 140594C
Authority
NO
Norway
Prior art keywords
phenylalkyl
alfa
piperidyl
omega
pyridyl
Prior art date
Application number
NO742970A
Other languages
English (en)
Other versions
NO140594B (no
NO742970L (no
Inventor
Adolf Langbein
Herbert Merz
Klaus Stockhaus
Gerhard Walther
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO742970L publication Critical patent/NO742970L/no
Publication of NO140594B publication Critical patent/NO140594B/no
Publication of NO140594C publication Critical patent/NO140594C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO742970A 1973-08-20 1974-08-19 Analogifremgangsmaate for fremstilling av farmakologisk aktive n-(1-(omega-fenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-karboksylsyreamider NO140594C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2341965A DE2341965C3 (de) 1973-08-20 1973-08-20 4- [N- (o-PyridyD- N-acyl] -aminolphenäthylpiperidine, Verfahren zu deren Herstellung sowie deren Verwendung bei der Bekämpfung von Schmerzzuständen

Publications (3)

Publication Number Publication Date
NO742970L NO742970L (no) 1975-03-17
NO140594B NO140594B (no) 1979-06-25
NO140594C true NO140594C (no) 1979-10-03

Family

ID=5890196

Family Applications (1)

Application Number Title Priority Date Filing Date
NO742970A NO140594C (no) 1973-08-20 1974-08-19 Analogifremgangsmaate for fremstilling av farmakologisk aktive n-(1-(omega-fenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-karboksylsyreamider

Country Status (26)

Country Link
US (1) US3933832A (no)
JP (1) JPS5049285A (no)
AT (2) AT334901B (no)
BE (1) BE818989A (no)
BG (1) BG24669A3 (no)
CA (1) CA1041513A (no)
CH (2) CH603630A5 (no)
CS (2) CS182263B2 (no)
DD (1) DD114260A5 (no)
DE (1) DE2341965C3 (no)
DK (1) DK141097C (no)
ES (2) ES429221A1 (no)
FI (1) FI57749C (no)
FR (1) FR2241314B1 (no)
GB (1) GB1468283A (no)
HU (1) HU167563B (no)
IE (1) IE40511B1 (no)
IL (1) IL45494A (no)
NL (1) NL7410989A (no)
NO (1) NO140594C (no)
PH (1) PH11999A (no)
PL (2) PL91562B1 (no)
RO (2) RO63050A (no)
SE (1) SE402285B (no)
SU (2) SU507229A3 (no)
ZA (1) ZA745306B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191683A (en) * 1975-05-28 1980-03-04 Ciba-Geigy Corporation Derivatives of 4-aminopiperidine as stabilizers for polymers
US4225606A (en) * 1975-09-23 1980-09-30 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)arylacetamides
US4791112A (en) * 1987-02-02 1988-12-13 The Boc Group, Inc. N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
USRE34201E (en) * 1989-04-20 1993-03-23 Anaquest, Inc. N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
WO2002068409A1 (en) 2001-02-23 2002-09-06 Merck & Co., Inc. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
US20040142013A1 (en) * 2001-07-13 2004-07-22 Flow Focusing, Inc. Implantable orthopedic surgical devices with controlled release antimicrobial component
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
US20060263401A1 (en) * 2001-07-13 2006-11-23 Flow Focusing, Inc. Formulation and Method for Preventing Infection
US7592360B2 (en) * 2003-06-04 2009-09-22 Merck & Co., Inc. 3-fluoro-piperidines as NMDA/NR2B antagonists
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) * 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) * 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
KR101506156B1 (ko) * 2007-04-23 2015-03-26 얀센 파마슈티카 엔.브이. 속해리성 도파민 2 수용체 길항제로서의 티아(디아)졸
AU2008240728B2 (en) * 2007-04-23 2013-01-10 Janssen Pharmaceutica N.V. 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
RU2480462C2 (ru) * 2007-04-23 2013-04-27 Янссен Фармацевтика Н.В. Производные пиридина, используемые в качестве быстро диссоциирующихся антагонистов допаминовых рецепторов 2
BRPI0915834A2 (pt) * 2008-07-03 2015-11-03 Janssen Pharmaceutica Nv 6-(1-piperazinil)-piridazinas substituídas como antagonistas do receptor de 5-ht6
DK2307374T3 (en) * 2008-07-31 2017-05-01 Janssen Pharmaceutica Nv PIPERAZIN-1-YLTRIFLUORMETHYL-SUBSTITUTED PYRIDINES AS QUICK DISSOCATING DOPAMIN-2 RECEPTOR ANTAGONISTS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1232147B (de) * 1961-04-13 1967-01-12 Bayer Ag Verfahren zur Herstellung von acylierten N-(Alkylaminoalkyl)-aminopyridinen
BE623427A (no) * 1961-10-10
US3141823A (en) * 1962-09-04 1964-07-21 Res Lab Dr C Janssen N V Method for producing analgesia
IL25840A (en) * 1965-07-24 1969-12-31 Bayer Ag Optically active pyridine derivatives and their production

Also Published As

Publication number Publication date
IL45494A (en) 1977-07-31
FR2241314B1 (no) 1977-11-10
AT334900B (de) 1977-02-10
FR2241314A1 (no) 1975-03-21
PL91512B1 (no) 1977-02-28
IL45494A0 (en) 1974-11-29
US3933832A (en) 1976-01-20
RO63050A (no) 1978-05-15
SU507229A3 (ru) 1976-03-15
JPS5049285A (no) 1975-05-01
ATA651274A (de) 1976-06-15
CH603630A5 (no) 1978-08-31
DE2341965B2 (de) 1978-06-01
NO140594B (no) 1979-06-25
IE40511L (en) 1975-02-20
CA1041513A (en) 1978-10-31
ES429234A1 (es) 1976-08-16
SE402285B (sv) 1978-06-26
SE7410540L (no) 1975-02-21
PH11999A (en) 1978-10-06
DK141097C (da) 1980-08-18
IE40511B1 (en) 1979-06-20
ZA745306B (en) 1976-04-28
GB1468283A (en) 1977-03-23
CS182263B2 (en) 1978-04-28
CS181767B2 (en) 1978-03-31
FI57749C (fi) 1980-10-10
SU504480A3 (ru) 1976-02-25
AU7248974A (en) 1976-02-19
RO63458A (fr) 1978-06-15
NL7410989A (nl) 1975-02-24
BE818989A (fr) 1975-02-19
FI57749B (fi) 1980-06-30
CH603631A5 (no) 1978-08-31
BG24669A3 (en) 1978-04-12
NO742970L (no) 1975-03-17
DD114260A5 (no) 1975-07-20
DK439974A (no) 1975-04-28
DK141097B (da) 1980-01-14
HU167563B (no) 1975-11-28
PL91562B1 (no) 1977-03-31
DE2341965C3 (de) 1979-01-25
FI234974A (no) 1975-02-21
AT334901B (de) 1977-02-10
DE2341965A1 (de) 1975-03-06
ATA651374A (de) 1976-06-15
ES429221A1 (es) 1976-08-16

Similar Documents

Publication Publication Date Title
NO140594C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive n-(1-(omega-fenylalkyl)-piperidyl-4)-n-(alfa-pyridyl)-karboksylsyreamider
DK139676C (da) Analogifremgangsmaade til fremstilling af carboxylsyreamidderivater
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO140854C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptid-amider
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO741580L (no) Analogifremgangsmåte for fremstilling av fysiologisk aktive acylaminosyreamider
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO140859C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive n-(metoksymetyl-furylmetyl)-6,7-benzomorfaner og -morfinaner
SE411753B (sv) Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(1-bensylpyrrolidinyl-2-alkyl)-bensamid
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO140496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO140978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
NO145793C (no) Analogifremgangsmaate for fremstilling av den fysiologisk aktive forbindelse n-(r-tetrahydrofurfuryl)-noroksymorfon
NO810816L (no) Utgangsmateriale for fremstilling av terapeutisk aktive aminosyrederivater
IT1020644B (it) Procedimento per la preparazione di ammidi di acidi
NO139439C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser
NO138250C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylaminer
NO137894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer
SE421693B (sv) Forfarande for framstellning av n-substituerade 1-amino-3-fenoxi-propanoler-(2)
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
NO136408C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser
NO137153C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive sulfamoylfenyl-pyrrolidoner
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO140062C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner